| 1 | [SID26660435] | Active | IC50 | 0.26 | uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2091, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 0.26 [uM] | | BioAssay | uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2091 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 2 | [SID26660435] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 3 | [SID26660435] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 4 | [SID26660435] | Active | Potency | 1.9953 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 5 | [SID26660435] | Active | Potency | 1.9953 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 6 | [SID26660435] | Active | IC50 | 6.55 | Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents [AID1903, Type: confirmatory] | large T antigen [Simian virus 40] [gi:297591903] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 6.55 [uM] | | BioAssay | Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents | | AID | 1903 | | BioAssay type | confirmatory | | Target | large T antigen [Simian virus 40] [gi:297591903] | | PubMed | | | Data Table |  |
|
| 7 | [SID26660435] | Active | Potency | 7.9433 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 8 | [SID26660435] | Active | Potency | 7.9433 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 9 | [SID26660435] | Active | Potency | 8.9125 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 10 | [SID26660435] | Active | Potency | 8.9125 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 11 | [SID26660435] | Active | Potency | 10.691 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 10.691 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 12 | [SID26660435] | Active | IC50 | 11.7 | Dose response confirmation of uHTS hits for Apaf-1 in a Fluorescent assay [AID588524, Type: confirmatory] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 11.7 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 in a Fluorescent assay | | AID | 588524 | | BioAssay type | confirmatory | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 13 | [SID26660435] | Active | Potency | 14.0919 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 14.0919 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 14 | [SID26660435] | Active | IC50 | 14.5 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 14.5 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 15 | [SID26660435] | Active | IC50 | 14.5 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 14.5 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 16 | [SID26660435] | Active | IC50 | 14.5 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 14.5 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 17 | [SID26660435] | Active | IC50 | 14.5 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 14.5 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 18 | [SID26660435] | Active | Potency | 17.7828 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 19 | [SID26660435] | Active | Potency | 17.7828 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 20 | [SID26660435] | Active | Potency | 19.9526 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 21 | [SID26660435] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID26660435] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 23 | [SID26660435] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 24 | [SID26660435] | Active | IC50 | 22.1 | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 22.1 [uM] | | BioAssay | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2073 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 25 | [SID26660435] | Active | IC50 | 25 | A biochemical assay using the ADP-Hunter methodology, purified TAg, and ATP to identify compounds that inhibit the ATPase activity of Tag - Counter Screen [AID2501, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | 25 [uM] | | BioAssay | A biochemical assay using the ADP-Hunter methodology, purified TAg, and ATP to identify compounds that inhibit the ATPase activity of Tag - Counter Screen | | AID | 2501 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID26660435] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 27 | [SID26660435] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 28 | [SID26660435] | Active | Potency | 50.1187 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 29 | [SID26660435] | Active | Potency | 50.1187 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 30 | [SID26660435] | Active | Potency | 50.1187 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 31 | [SID26660435] | Active | Potency | 50.1187 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 32 | [SID26660435] | Active | Potency | 79.4328 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 33 | [SID26660435] | Active | Potency | 79.4328 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 34 | [SID26660435] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) [AID488796, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) | | AID | 488796 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 35 | [SID26660435] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) [AID488796, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) | | AID | 488796 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 36 | [SID26660435] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 37 | [SID26660435] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 38 | [SID26660435] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 39 | [SID26660435] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 40 | [SID26660435] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID2176, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 2176 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 41 | [SID26660435] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID2176, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 2176 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 42 | [SID26660435] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 43 | [SID26660435] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 44 | [SID26660435] | Active | | | Single concentration confirmation of uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID504614, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 504614 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 45 | [SID26660435] | Active | | | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen [AID1422, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen | | AID | 1422 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 46 | [SID26660435] | Active | | | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen [AID1422, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen | | AID | 1422 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 47 | [SID125140486] | Active | | | A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37 [AID588478, Type: other] | ubiquitin C-terminal hydrolase UCH37 [Homo sapiens] [gi:4877999] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 125140486 | | CID | 16682085 | | Outcome | Active | | BioAssay | A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37 | | AID | 588478 | | BioAssay type | other | | Target | ubiquitin C-terminal hydrolase UCH37 [Homo sapiens] [gi:4877999] | | PubMed | | | Data Table |  |
|
| 48 | [SID26660435] | Active | | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. [AID1496, Type: screening] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1496 | | BioAssay type | screening | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 49 | [SID26660435] | Active | | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. [AID1496, Type: screening] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1496 | | BioAssay type | screening | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 50 | [SID26660435] | Active | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26660435 | | CID | 16682085 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|